![Christine Wilkinson-Blanc](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christine Wilkinson-Blanc
Corporate Officer/Principal presso Centre Hospitalier Universitaire de Lille
Posizioni attive di Christine Wilkinson-Blanc
Società | Posizione | Inizio | Fine |
---|---|---|---|
Centre Hospitalier Universitaire de Lille | Corporate Officer/Principal | - | - |
Storia della carriera di Christine Wilkinson-Blanc
Precedenti posizioni note di Christine Wilkinson-Blanc
Società | Posizione | Inizio | Fine |
---|---|---|---|
THOR MEDICAL | Direttore Tecnico/Scientifico/R&S | 10/08/2020 | 08/11/2021 |
GE Healthcare Ltd. (United Kingdom)
![]() GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Direttore Tecnico/Scientifico/R&S | - | - |
Aventis International, Inc. | Corporate Officer/Principal | - | - |
Akamis Bio Ltd.
![]() Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Christine Wilkinson-Blanc
University of Lyon | Doctorate Degree |
Centre Hospitalier Universitaire de Lille | Graduate Degree |
Université des Sciences et Technologies de Lille | Doctorate Degree |
Statistiche
Distribuzione geografica
Francia | 4 |
Regno Unito | 3 |
Stati Uniti | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 2 |
Settori
Health Technology | 4 |
Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
Akamis Bio Ltd.
![]() Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
GE Healthcare Ltd. (United Kingdom)
![]() GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Health Technology |
Aventis International, Inc. | |
Nordic Nanovector ASA
![]() Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |